Skip to content

Prevention of seizures in Brain Injury patients

Assessing Phenytoin and Levetiracetam Efficacy, Cost-Effectiveness, and CYP2C9/SV2A Polymorphism in Early Post-Traumatic Seizures: A Multicentric Prospective Randomized Trial

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/02/080151
Enrollment
1260
Registered
2025-02-07
Start date
Unknown
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G405- Epileptic seizures related to external causes

Interventions

Intervention1: Phenytoin: The Phenytoin group will be given a loading dose of phenytoin 20 mg/kg intravenously (maximum, 2 gm) at 50 mg per minute and then started on a maintenance dose (5-6 mg/kg/d,

Sponsors

Indian Council of Medical Research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients of severe blunt TBI with GCS score less than 10. Patients with GCS of more than 10 in the presence of computed tomographic imaging findings consistent with brain injury. Patients with penetrating injury.

Exclusion criteria

Exclusion criteria: 1.Females of childbearing age with urine pregnancy test positive. 2.Devastating brain injury with expected or confirmed brain death within 48 hours of hospital admission, 3.Prehospital use of anticonvulsants 4.Development of seizures before enrolment. 5.Any risk factor for Post-Traumatic Seizures like Liver Disease, Renal failure, drugs lowering seizure threshold, severe depression {have undergone or may need Electro Convulsive Therapy(ECT)}

Design outcomes

Primary

MeasureTime frame
To evaluate the incidence of early clinical seizure in each of the three treatment groups.Timepoint: 7 Days

Secondary

MeasureTime frame
Assessment of Glasgow Coma Scale & Glasgow Outcome Scale in the three treatment groups.Timepoint: 7 days and 6 months;To evaluate the effect of genetic polymorphisms on seizure incidence among study participants.Timepoint: 7 days, 6 months and 1 year;Incremental Cost-effective analysis between phenytoin and levetiracetam.Timepoint: 6 months and 1 year

Countries

India

Contacts

Public ContactDr Shoban Babu Varthya

All India Institute Of Medical Sciences, Jodhpur

gosaljs@aiimsjodhpur.edu.in6283475891

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026